HIV-1 Clade B pol Evolution following Primary Infection

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Hightower, George K ^a   May, Susanne J ^b   Pérez Santiago, Josué ^a   Pacold, Mary E ^c   Wagner, Gabriel A ^a   Little, Susan J ^a   Richman, Douglas D ^a,d   Mehta, Sanjay R ^a   Smith, Davey M ^a,d   Pond, Sergei L Kosakovsky ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Life Technologies   (United States)

^d VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; HLA ANTIGEN; NUCLEOTIDE; POL PROTEIN;

ADULT; ARTICLE; BLOOD ANALYSIS; CD4 LYMPHOCYTE COUNT; CLADISTICS; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENETIC CONSERVATION; GENETIC VARIABILITY; HAPLOTYPE; HLA SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MOLECULAR EVOLUTION; NONHUMAN; NUCLEOTIDE SEQUENCE; POPULATION RESEARCH; PRIMARY INFECTION; SEQUENCE ANALYSIS; UNINDEXED SEQUENCE; VIRUS LOAD; VIRUS TRANSMISSION;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; EVOLUTION, MOLECULAR; FEMALE; GENES, POL; GENES, VIRAL; GENETIC VARIATION; HIV INFECTIONS; HIV-1; HLA ANTIGENS; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; VIRAL LOAD; YOUNG ADULT;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84879509059     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068188     Document Type: Article

References (34)

1. Korber B, Muldoon M, Theiler J, Gao F, Gupta R, et al. (2000) Timing the ancestor of the HIV-1 pandemic strains. Science 288: 1789-1796.
2. Leitner T, Kumar S, Albert J, (1997) Tempo and mode of nucleotide substitutions in gag and env gene fragments in human immunodeficiency virus type 1 populations with a known transmission history. J Virol 71: 4761-4770.
3. Frost SD, Wrin T, Smith DM, Kosakovsky Pond SL, Liu Y, et al. (2005) Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection. Proc Natl Acad Sci U S A 102: 18514-18519.
4. McNearney T, Hornickova Z, Markham R, Birdwell A, Arens M, et al. (1992) Relationship of human immunodeficiency virus type 1 sequence heterogeneity to stage of disease. Proc Natl Acad Sci U S A 89: 10247-10251.
5. Wolfs TF, Zwart G, Bakker M, Goudsmit J, (1992) HIV-1 genomic RNA diversification following sexual and parenteral virus transmission. Virology 189: 103-110.
6. Keele BF, Giorgi EE, Salazar-Gonzalez JF, Decker JM, Pham KT, et al. (2008) Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci U S A 105: 7552-7557.
7. Lemey P, Rambaut A, Pybus OG, (2006) HIV evolutionary dynamics within and among hosts. AIDS Rev 8: 125-140.
8. Price DA, Goulder PJ, Klenerman P, Sewell AK, Easterbrook PJ, et al. (1997) Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc Natl Acad Sci U S A 94: 1890-1895.
9. Addo MM, Yu XG, Rathod A, Cohen D, Eldridge RL, et al. (2003) Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J Virol 77: 2081-2092.
10. Rhee SY, Taylor J, Wadhera G, Ben-Hur A, Brutlag DL, et al. (2006) Genotypic predictors of human immunodeficiency virus type 1 drug resistance. Proc Natl Acad Sci U S A 103: 17355-17360.
11. Abecasis AB, Vandamme AM, Lemey P, (2009) Quantifying differences in the tempo of human immunodeficiency virus type 1 subtype evolution. J Virol 83: 12917-12924.
12. Gifford RJ, de Oliveira T, Rambaut A, Pybus OG, Dunn D, et al. (2007) Phylogenetic surveillance of viral genetic diversity and the evolving molecular epidemiology of human immunodeficiency virus type 1. J Virol 81: 13050-13056.
13. Smith DM, May SJ, Tweeten S, Drumright L, Pacold ME, et al. (2009) A public health model for the molecular surveillance of HIV transmission in San Diego, California. AIDS 23: 225-232.
14. Little SJ, Holte S, Routy JP, Daar ES, Markowitz M, et al. (2002) Antiretroviral-drug resistance among patients recently infected with HIV. N Engl J Med 347: 385-394.
15. Hecht FM, Wang L, Collier A, Little S, Markowitz M, et al. (2006) A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection. J Infect Dis 194: 725-733.
16. Pacold ME, Pond SL, Wagner GA, Delport W, Bourque DL, et al. (2012) Clinical, virologic, and immunologic correlates of HIV-1 intraclade B dual infection among men who have sex with men. AIDS 26: 157-165.
17. Pacold M, Smith D, Little S, Cheng PM, Jordan P, et al. (2010) Comparison of methods to detect HIV dual infection. AIDS Res Hum Retroviruses 26: 1291-1298.
18. Kosakovsky Pond SL, Posada D, Stawiski E, Chappey C, Poon AF, et al. (2009) An evolutionary model-based algorithm for accurate phylogenetic breakpoint mapping and subtype prediction in HIV-1. PLoS Comput Biol 5: e1000581.
19. Tamura K, Nei M, (1993) Estimation of the number of nucleotide substitutions in the control region of mitochondrial DNA in humans and chimpanzees. Mol Biol Evol 10: 512-526.
20. Pond SL, Frost SD, Muse SV, (2005) HyPhy: hypothesis testing using phylogenies. Bioinformatics 21: 676-679.
21. Felsenstein J, (1981) Evolutionary trees from DNA sequences: a maximum likelihood approach. J Mol Evol 17: 368-376.
22. Muse SV, Gaut BS, (1994) A likelihood approach for comparing synonymous and nonsynonymous nucleotide substitution rates, with application to the chloroplast genome. Mol Biol Evol 11: 715-724.
23. Aldous JL, Pond SK, Poon A, Jain S, Qin H, et al. (2012) Characterizing HIV Transmission Networks across the United States. Clin Infect Dis.
24. Pond SL, Frost SD, Grossman Z, Gravenor MB, Richman DD, et al. (2006) Adaptation to different human populations by HIV-1 revealed by codon-based analyses. PLoS Comput Biol 2: e62.
25. Liu Y, McNevin J, Cao J, Zhao H, Genowati I, et al. (2006) Selection on the human immunodeficiency virus type 1 proteome following primary infection. J Virol 80: 9519-9529.
26. Wertheim JO, Fourment M, Kosakovsky Pond SL, (2012) Inconsistencies in estimating the age of HIV-1 subtypes due to heterotachy. Mol Biol Evol 29: 451-456.
27. Hue S, Pillay D, Clewley JP, Pybus OG, (2005) Genetic analysis reveals the complex structure of HIV-1 transmission within defined risk groups. Proc Natl Acad Sci U S A 102: 4425-4429.
28. Brumme ZL, Brumme CJ, Carlson J, Streeck H, John M, et al. (2008) Marked epitope- and allele-specific differences in rates of mutation in human immunodeficiency type 1 (HIV-1) Gag, Pol, and Nef cytotoxic T-lymphocyte epitopes in acute/early HIV-1 infection. J Virol 82: 9216-9227.
29. Henn MR, Boutwell CL, Charlebois P, Lennon NJ, Power KA, et al. (2012) Whole genome deep sequencing of HIV-1 reveals the impact of early minor variants upon immune recognition during acute infection. PLoS Pathog 8: e1002529.
30. Brumme ZL, Tao I, Szeto S, Brumme CJ, Carlson JM, et al. (2008) Human leukocyte antigen-specific polymorphisms in HIV-1 Gag and their association with viral load in chronic untreated infection. AIDS 22: 1277-1286.
31. Brumme ZL, Brumme CJ, Heckerman D, Korber BT, Daniels M, et al. (2007) Evidence of differential HLA class I-mediated viral evolution in functional and accessory/regulatory genes of HIV-1. PLoS Pathog 3: e94.
32. Buskin SE, Ellis GM, Pepper GG, Frenkel LM, Pergam SA, et al. (2008) Transmission cluster of multiclass highly drug-resistant HIV-1 among 9 men who have sex with men in Seattle/King County, WA, 2005-2007. J Acquir Immune Defic Syndr 49: 205-211.
33. Pao D, Fisher M, Hue S, Dean G, Murphy G, et al. (2005) Transmission of HIV-1 during primary infection: relationship to sexual risk and sexually transmitted infections. Aids 19: 85-90.
34. Hue S, Clewley JP, Cane PA, Pillay D, (2004) HIV-1 pol gene variation is sufficient for reconstruction of transmissions in the era of antiretroviral therapy. AIDS 18: 719-728.